Bankstocks.com is a public web site operated by an individual who also operates an investment advisory firm that serve as an investment adviser to hedge funds (the "Firm"). Some articles are authored by employees of the Firm while others are authored by third parties. Under no circumstances does any article posted on Bankstocks.com represent a recommendation to buy or sell a security. This article is intended to provide insight into the financial services industry and is not a solicitation of any kind. The Firm does not vouch for the accuracy of any information contained in any article posted herein and the views expressed in any article herein do not necessarily reflect the views of the Firm. The Firm buys and sells securities on behalf of its fund investors and may do so, before and after any particular article herein is published, with respect to the securities discussed in any article posted herein. The Firm’s appraisal of a company's prospects is only one factor that affects the Firm’s decision whether to buy or sell shares in that company. Other factors might include, but are not limited to, the presence of mandatory limits on individual positions, decisions regarding portfolio exposures, and general market conditions and liquidity needs. As such, there may not always be consistency between the views expressed in this article and the Firm’s trading on behalf of its fund investors. There may be conflicts between the content posted on Bankstocks.com and the interests of the Firm. For an explanation of these conflicts, including an explanation of our trading policy, and how we resolve them, refer to the page marked “Our Trading Policy.”
Neither the authors nor any Bankstocks.com team members can provide investment advice or respond to individual requests for recommendations. However, we encourage your feedback and welcome your comments on any of the articles on this site. Neither the authors nor Bankstocks.com has undertaken any responsibility to update any portion of this article in response to events which may transpire subsequent to its original publication date.
Tuesday’s Headlines: Shelton’s Fed confirmation in doubt
By Matt Stichnoth,
MarketWatch: Judy Shelton’s Fed confirmation in doubt as a third Republican senator will oppose nomination
Financial Times: Global M&A recovers on vaccine hopes and US political stability
Yahoo Finance: Warren Buffett’s Berkshire loads up on Pfizer, other pharma stocks in Q3; exits Costco
Financial Times: Bank regulator calls for dividends to remain on hold
Wall Street Journal: SEC Pursues Plan Requiring Chinese Firms to Use Auditors Overseen by U.S.
CNBC.com: U.S. ETF market tops $5 trillion in assets as investors stampede into stocks on vaccine hopes
Financial Times: Clarida signals possible changes to Fed bond-buying programme
CNBC.com: Full impact of pandemic on Europe’s banks won’t be clear until 2021, official says
Wall Street Journal: Korean Appetite for U.S. Commercial Real Estate Heats Up During Pandemic
New York Post: Top dealmaker leaves Goldman Sachs to run Michael Dell’s investment firm